| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/03/2008 | US7381535 Methods and compositions for detecting receptor-ligand interactions in single cells |
| 06/03/2008 | US7381534 Immunoglobulin binding immunogenic polypeptide of given sequence; test kits for allergy detection |
| 06/03/2008 | US7381532 Incubating with polymerase component; FEN nuclease splitting; detecting and/or measuring fragment released |
| 06/03/2008 | US7381531 Apparatus which utilizes a complex of an anti-cocaine aptamer and diethylthiotricarbocyanine dyes to detect cocaine in solution; drug testing; calorimetric sensor |
| 06/03/2008 | US7381524 Using immunoglobulin specific to turkey astrovirus capsid protein as tool for detecting single-stranded RNA viral infection in avians; immunodiagnostics |
| 06/03/2008 | US7381523 Methods for identifying compounds for treating diabetes mellitus |
| 06/03/2008 | US7381522 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 06/03/2008 | US7381467 Particle size of 1-10 mu m, coercive force of 2.39-11.94 kA/m (30-150 oersted), saturation magnetization of 0.5-40 A.m2/kg (0.5-40 emu/g; peak value of wavelength of fluorescence is 350-750 nm when the particle is excited by light with a wavelength of 250-600 nm; diagnoses and environmental assessment |
| 06/03/2008 | US7381413 Methods and products related to metabolic interactions in disease |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | US7381411 Preventing influenza virus cell binding; schizophrenia; diagnosing chronic viral disease associated with cancer development |
| 06/03/2008 | US7381409 Immunoglobulin specific to transforming growth factor binding protein for use as tool in prevention and treatment of osteoporosis and bone disorders |
| 06/03/2008 | US7381401 T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase |
| 06/03/2008 | US7381383 Hermetic door and retort as interface for removal of vapors of heavy metals and other hazardous wastes such as dioxins from object being heated under reduced pressure in second hermetic chamber; condensation of gases at the hermetic door is prevented so that condensates can be removed without stopping |
| 06/03/2008 | US7381195 Hematocrit sensor |
| 06/03/2008 | US7380468 Device for integrating electrodes characterizing the flow of a multiphase fluid in a tubing |
| 06/03/2008 | US7380441 High throughput screening methods for lubricating oil compositions |
| 06/03/2008 | US7380438 Apparatus and method for providing a fluid cut measurement of a multi-liquid mixture compensated for entrained gas |
| 06/03/2008 | CA2671875A1 Analytical method for analyzing c-terminus truncation |
| 06/03/2008 | CA2435320C Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer |
| 06/03/2008 | CA2296072C Oligonucleotide primers for efficient reverse transcription of hepatitis c virus (hcv) rna and methods of use thereof |
| 06/03/2008 | CA2279846C Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 06/03/2008 | CA2261018C Treatment and diagnosis of cancer |
| 06/03/2008 | CA2231186C Optical apparatus for performing an immunoassay |
| 06/03/2008 | CA2225382C Sialic acid derivatives |
| 06/03/2008 | CA2220563C Protein production in transgenic alfalfa plants |
| 06/03/2008 | CA2195528C Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 05/29/2008 | WO2008064336A2 Autoimmune disease biomarkers |
| 05/29/2008 | WO2008064241A2 Method and apparatus for enhanced bacteriophage-based diagnostic assay |
| 05/29/2008 | WO2008064232A2 Fluidic antibody-containing devices and methods |
| 05/29/2008 | WO2008064067A2 Method for the sequential analysis of different components in a single biological sample and reagents therefor |
| 05/29/2008 | WO2008064043A2 Methods for determining therapeutic efficacy of quinolone analogs |
| 05/29/2008 | WO2008063934A2 Methods for differentiating insulin-producing beta cells from pancreatic precursor cells |
| 05/29/2008 | WO2008063928A2 Proteomic analysis of cervical-vaginal fluids for detecting intra-uterine infection or determining pre-term delivery risk in a pregnant female |
| 05/29/2008 | WO2008063838A2 Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross-reactive organisms |
| 05/29/2008 | WO2008063821A2 Novel standard reference solutions |
| 05/29/2008 | WO2008063783A2 Biomarkers related to metabolic age and methods using the same |
| 05/29/2008 | WO2008063770A2 Reducing optical interference in a fluidic device |
| 05/29/2008 | WO2008063758A2 Multifunctional encoded particles for high-throughput analysis |
| 05/29/2008 | WO2008063663A2 Poly (ethylene glycol) anti-body detection assays and kits for performing thereof |
| 05/29/2008 | WO2008063479A2 Pancreatic cancer biomarkers |
| 05/29/2008 | WO2008063406A2 A platform for binding assays with dual multiplexing capability |
| 05/29/2008 | WO2008063405A1 Test-sensor cartridge |
| 05/29/2008 | WO2008063404A2 Test-sensor cartridge |
| 05/29/2008 | WO2008063378A2 Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| 05/29/2008 | WO2008063369A2 Biomarkers for neurological conditions |
| 05/29/2008 | WO2008063213A2 Uses and compositions for treatment of psoriatic arthritis |
| 05/29/2008 | WO2008063145A1 Device for examining animal and vegetable products |
| 05/29/2008 | WO2008063136A1 Apparatus for processing a sample in a liquid droplet and method of using the same |
| 05/29/2008 | WO2008063135A1 Apparatus for processing a sample in a liquid droplet and method of using the same |
| 05/29/2008 | WO2008063056A2 Gas analyzing system, lithographic apparatus and method of improving the sensitivity of a gas analyzing system |
| 05/29/2008 | WO2008062907A1 Substance capable of inhibiting cytokinin signaling |
| 05/29/2008 | WO2008062882A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO RABBIT-DERIVED IgG ANTIBODY |
| 05/29/2008 | WO2008062660A1 Luminescent silicon nanocluster, method for producing the same, and agent for labeling biological substance |
| 05/29/2008 | WO2008062520A1 Drug efficacy testing method for antithrombotic agent |
| 05/29/2008 | WO2008062439A2 Non-invasive blood glucose measurement using mid-infrared absorption spectroscopy |
| 05/29/2008 | WO2008062314A2 Circulating ve-cadherin as a predictive marker of sensitivity or resistance to anti-tumoral treatment, and improved method for the detection of soluble proteins. |
| 05/29/2008 | WO2008062184A1 Compounds |
| 05/29/2008 | WO2008062168A1 Biomolecules |
| 05/29/2008 | WO2008062105A1 Method for predicting the response to a therapy |
| 05/29/2008 | WO2008062099A1 Measurement device, system and method |
| 05/29/2008 | WO2008062065A1 New thermal analysis device |
| 05/29/2008 | WO2008062048A2 Methods for optically detecting multiple analytes in a liquid sample with a compressible microfluidic device |
| 05/29/2008 | WO2008061978A2 Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of troponin t and nt-probnp |
| 05/29/2008 | WO2008061953A1 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 05/29/2008 | WO2008061684A1 Anti-idiotype conjugate and its use as a standard in an immunassay |
| 05/29/2008 | WO2008061673A2 Drug discovery for cancer |
| 05/29/2008 | WO2008061660A2 Method and device for treating biological cells on a substrate |
| 05/29/2008 | WO2008061626A1 Method for detecting pyrophosphate by means of bioluminescence detection |
| 05/29/2008 | WO2008061552A1 Blood glucose meter capable of wireless communication |
| 05/29/2008 | WO2008061542A1 Ion sensor for fluid and method for its manufacture |
| 05/29/2008 | WO2008061489A1 Apparatus and method for measuring biological and electronic characteristics of a sample |
| 05/29/2008 | WO2008061377A1 Novel receptor for cd40l and uses thereof |
| 05/29/2008 | WO2008061370A1 Diagnostic method to detect endometriosis |
| 05/29/2008 | WO2008061363A1 Biomolecule compatible silica particles |
| 05/29/2008 | WO2008061320A1 Classification apparatus and method |
| 05/29/2008 | WO2008061315A1 Chemical analyser |
| 05/29/2008 | WO2008045767A3 Detection of gadolinium chelates |
| 05/29/2008 | WO2008042232A3 Method and system for displaying genetic and genealogical data |
| 05/29/2008 | WO2008040998A3 Systems and methods for determining a substantially hematocrit independent analyte concentration |
| 05/29/2008 | WO2008035252A3 A sensor device for and a method of sensing particles |
| 05/29/2008 | WO2008033164B1 Magnetic particle tagged reagents and techniques |
| 05/29/2008 | WO2008032235A3 Methods for analysing protein samples based on the identification of c-terminal peptides |
| 05/29/2008 | WO2008029262A3 Three-phase cyclonic separator with a debris trap |
| 05/29/2008 | WO2008028162A3 Methods of screening agents for activity using teleosts |
| 05/29/2008 | WO2008027078A3 Nanobioelectronics |
| 05/29/2008 | WO2008026102A3 Detection of hydrogen peroxide released by enzyme-catalyzed oxidation of an analyte |
| 05/29/2008 | WO2008024495A3 Biomarkers associated with age-related macular degeneration |
| 05/29/2008 | WO2008021552A9 Biased ligands and methods of identifying same |
| 05/29/2008 | WO2008020823A3 Cooperative reporter systems, components, and methods for analyte detection |
| 05/29/2008 | WO2008019375A9 Proteomic patterns of cancer prognostic and predictive signatures |
| 05/29/2008 | WO2008009802A3 Drugs comprising an inhibitor of class 1 alpha mannosidase for the treatment of sarcoglycanopathies |
| 05/29/2008 | WO2008002165A3 A method, assay and kit for prediction and treatment of a human subject infected with a virus |
| 05/29/2008 | WO2007143161A3 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods |
| 05/29/2008 | WO2007140291A3 Expression quantification using mass spectrometry |
| 05/29/2008 | WO2007133593A3 Methods, systems and computer programs for assessing chd risk using weighted hdl particle number measurements |
| 05/29/2008 | WO2007121017A3 Mutations and polymorphisms of fms-like tyrosine kinase 4 |
| 05/29/2008 | WO2007120689A3 Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual |
| 05/29/2008 | WO2007117330A3 Latent protein c assays and their uses for diagnosis and/or prognosis in systemic inflammatory response syndromes |
| 05/29/2008 | WO2007114979A3 Gene disruptons, compositions and methods relating thereto |